AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

A Method to Generate Novel Bioactive Molecules

Detailed Technology Description
UC San Diego inventors have invented a very general method to design and create new compounds with anti-bacterial, anti-fungal, anti-cancer, or other bioactive properties. Different from the existing art, where the biological effect of a compound must be determined, this invention allows for compounds to be designed and created with these effects known a priori. For example, this shortcoming, which the current invention overcomes, is part of the existing art being applied to anti-bacterial synthesis—such as mutational biosynthesis, genetic engineering, structure-based drug design, or interrogation of novel natural products.Slide Show Presentation
Supplementary Information
Patent Number: US20130211100A1
Application Number: US13825792A
Inventor: Palsson, Bernhard | Charusanti, Pep
Priority Date: 29 Oct 2010
Priority Number: US20130211100A1
Application Date: 1 May 2013
Publication Date: 15 Aug 2013
IPC Current: C12Q000118 | C12N000120
US Class: 548453 | 43500611 | 435032 | 4352535
Title: Method to Generate Novel Bioactive Molecules
Usefulness: Method to Generate Novel Bioactive Molecules
Summary: The methods are useful for identifying a bioactive compound in a culture; and for identifying a genomic mutation in an organism (all claimed).
Novelty: Identifying a bioactive compound in a culture comprises co-culturing two or more organisms, detecting inhibition of growth of the target organisms, and detecting the presence of one or more bioactive compounds in the co-culture
Industry
Biomedical
Sub Category
DNA/Gene Engineering
Application No.
9080199
Others

State Of Development

Experimental work to create a positive bioassay has been completed and the invention is already being applied to the creation of novel anti-bacterial agents.


Other Information

Access the recommendation on F1000 Prime 


Tech ID/UC Case

19978/2008-230-0


Related Cases

2008-230-0

*Abstract
None
*IP Issue Date
Jul 14, 2015
*Principal Investigator

Name: Pep Charusanti

Department:


Name: Bernhard Palsson

Department:

Country/Region
USA

For more information, please click Here
Mobile Device